These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 27056558)

  • 1. Intraperitoneal chemotherapy hyperthermia (HIPEC) for peritoneal carcinomatosis of ovarian cancer origin by fluid and CO2 recirculation using the closed abdomen technique (PRS-1.0 Combat): A clinical pilot study.
    Sánchez-García S; Villarejo-Campos P; Padilla-Valverde D; Amo-Salas M; Martín-Fernández J
    Int J Hyperthermia; 2016 Aug; 32(5):488-95. PubMed ID: 27056558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental development of an intra-abdominal chemohyperthermia model using a closed abdomen technique and a PRS-1.0 Combat CO2 recirculation system.
    Sánchez-García S; Padilla-Valverde D; Villarejo-Campos P; Martín-Fernández J; García-Rojo M; Rodríguez-Martínez M
    Surgery; 2014 Apr; 155(4):719-25. PubMed ID: 24502804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Closed hyperthermic intraperitoneal chemotherapy with CO
    Diaz E; Fabra I; Vicente E; Quijano Y; Duran H; Malave L; Ruiz P; Costantini G; Nola V; Caruso R; Ferri V
    Surg Oncol; 2023 Feb; 46():101901. PubMed ID: 36638761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritonectomy procedures and HIPEC in the treatment of peritoneal carcinomatosis from ovarian cancer: Long-term outcomes and perspectives from a high-volume center.
    Muñoz-Casares FC; Medina-Fernández FJ; Arjona-Sánchez Á; Casado-Adam Á; Sánchez-Hidalgo JM; Rubio MJ; Ortega-Salas R; Muñoz-Villanueva MC; Rufián-Peña S; Briceño FJ
    Eur J Surg Oncol; 2016 Feb; 42(2):224-33. PubMed ID: 26673283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laparoscopic cytoreductive surgery and HIPEC is effective regarding peritoneum tissue paclitaxel distribution.
    Padilla-Valverde D; Villarejo P; Redondo J; Oyarzabal J; Estella A; Palomino T; Fernandez E; Sanchez S; Sánchez S; Faba P; Baladron V; Alberca A; Montenegro O; Fernández J; Marta P; Martín J
    Clin Transl Oncol; 2019 Sep; 21(9):1260-1269. PubMed ID: 30761508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoreductive surgery and intraoperative hyperthermic intraperitoneal chemotherapy with paclitaxel: a clinical and pharmacokinetic study.
    de Bree E; Rosing H; Filis D; Romanos J; Melisssourgaki M; Daskalakis M; Pilatou M; Sanidas E; Taflampas P; Kalbakis K; Beijnen JH; Tsiftsis DD
    Ann Surg Oncol; 2008 Apr; 15(4):1183-92. PubMed ID: 18239973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Onset of Intra-Abdominal Adhesions During Closed-Abdomen Hyperthermic Intraperitoneal Chemotherapy.
    Lotti M; Giulii Capponi M; Campanati L; Poiasina E; Ansaloni L; Poletti E; Frigerio L
    J Laparoendosc Adv Surg Tech A; 2016 Dec; 26(12):997-1002. PubMed ID: 27705085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal carcinomatosis: intraoperative parameters in open (coliseum) versus closed abdomen HIPEC.
    Halkia E; Tsochrinis A; Vassiliadou DT; Pavlakou A; Vaxevanidou A; Datsis A; Efstathiou E; Spiliotis J
    Int J Surg Oncol; 2015; 2015():610597. PubMed ID: 25785194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morbidity and mortality outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with primary and recurrent advanced ovarian cancer.
    Cascales Campos P; Gil J; Parrilla P
    Eur J Surg Oncol; 2014 Aug; 40(8):970-5. PubMed ID: 24035502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Routine second-look after surgical treatment of colonic peritoneal carcinomatosis.
    Delhorme JB; Triki E; Romain B; Meyer N; Rohr S; Brigand C
    J Visc Surg; 2015 Jun; 152(3):149-54. PubMed ID: 25650364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Global End-Diastolic Volume (GEDV) Could Be More Appropiate to Fluid Management Than Central Venous Pressure (CVP) During Closed Hyperthermic Intrabdominal Chemotherapy with CO
    Redondo FJ; Padilla D; Villarejo P; Baladron V; Faba P; Sánchez S; Muñoz-Rodríguez JR; Bejarano N
    J Invest Surg; 2018 Aug; 31(4):321-327. PubMed ID: 28557569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant intraperitoneal chemotherapy with paclitaxel for the radical surgical treatment of peritoneal carcinomatosis in ovarian cancer: a prospective pilot study.
    Muñoz-Casares FC; Rufián S; Arjona-Sánchez Á; Rubio MJ; Díaz R; Casado Á; Naranjo Á; Díaz-Iglesias CJ; Ortega R; Muñoz-Villanueva MC; Muntané J; Aranda E
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):267-74. PubMed ID: 21499894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does early post-operative intraperitoneal chemotherapy (EPIC) for patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) make a difference?
    Tan GH; Ong WS; Chia CS; Tham CK; Soo KC; Teo MC
    Int J Hyperthermia; 2016 May; 32(3):281-8. PubMed ID: 26862667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperthermic chemotherapy intra-abdominal laparoscopic approach: development of a laparoscopic model using CO
    Sánchez-García S; Padilla-Valverde D; Villarejo-Campos P; García-Santos EP; Martín-Fernández J
    Int J Hyperthermia; 2017 Sep; 33(6):684-689. PubMed ID: 28540790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of peritoneal carcinomatosis from ovarian cancer by surgical cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Robella M; Vaira M; Marsanic P; Mellano A; Borsano A; Cinquegrana A; Sottile A; De Simone M
    Minerva Chir; 2014 Feb; 69(1):27-35. PubMed ID: 24675244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new animal model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing mice in the treatment of peritoneal carcinomatosis of ovarian origin.
    Miailhe G; Arfi A; Mirshahi M; Eveno C; Pocard M; Touboul C
    J Visc Surg; 2018 Jun; 155(3):183-189. PubMed ID: 29108718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative hyperthermic intraperitoneal chemotherapy with docetaxel as second-line treatment for peritoneal carcinomatosis of gynaecological origin.
    de Bree E; Romanos J; Michalakis J; Relakis K; Georgoulias V; Melissas J; Tsiftsis DD
    Anticancer Res; 2003; 23(3C):3019-27. PubMed ID: 12926156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIPEC plus EPIC paclitaxel for maximal perioperative treatments of advanced epithelial ovarian cancer. Long-term results of a pilot study.
    Sugarbaker PH; Stuart OA
    Surg Oncol; 2020 Dec; 35():441-446. PubMed ID: 33039850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are there intra-operative hemodynamic differences between the Coliseum and closed HIPEC techniques in the treatment of peritoneal metastasis? A retrospective cohort study.
    Rodríguez Silva C; Moreno Ruiz FJ; Bellido Estévez I; Carrasco Campos J; Titos García A; Ruiz López M; González Poveda I; Toval Mata JA; Mera Velasco S; Santoyo Santoyo J
    World J Surg Oncol; 2017 Feb; 15(1):51. PubMed ID: 28222738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal carcinomatosis. Preliminary results and cost from two centers in Greece.
    Spiliotis J; Tentes AA; Vaxevanidou A; Korakianitis OS; Rogdakis A; Mirelis CG; Datsis AC; Kekelos S
    J BUON; 2008; 13(2):205-10. PubMed ID: 18555466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.